Core Viewpoint - Guoxin Health is actively collaborating with insurance brokerage firms, health management service providers, and medical service institutions to explore a data-driven full-chain service model for health insurance, covering product design, marketing, underwriting, claims, and risk control [2] Group 1: Collaboration and Innovation - The company has established deep cooperative relationships with several domestic insurance companies to promote the implementation of innovative health insurance service models [2] - Guoxin Health is involved in projects such as the operation of public data authorization in Hangzhou and the personal medical insurance data authorization query in Pingxiang, Jiangxi, to enhance data compliance and operational practices [2] Group 2: Data Integration and Development - Guoxin Health has jointly established a company with Hubei Data Group to operate health medical big data in Central China, aiming to integrate and utilize health medical data resources within Hubei Province [2] - The newly formed company serves as a pilot for public data authorization operations in the "Three Medical" fields, facilitating the development and utilization of health medical data resources [2]

Core Insights - The construction of a national-level trusted data space for the pharmaceutical industry will follow three main strategies: government-enterprise co-management, pilot projects in subspaces, and a whitelist approach for gradual implementation [1][2] Group 1: Data Governance in Pharmaceutical Industry - The trusted data space is based on the drug traceability platform launched in 2023, which integrates data across the entire chain of drug production, distribution, and usage [1] - The focus will initially be on mature areas such as biological products, medical devices, and anesthetic drugs, with steady progress being made in these areas [1] Group 2: AI and Healthcare - Key breakthrough areas for AI in healthcare include innovative drug development, intelligent health management, and medical diagnostic assistance [1] - The potential for AI to enhance health management services and reduce misdiagnosis rates is significant, facilitated by the integration of health data [1] Group 3: Collaboration with Guizhou - The company anticipates that the Digital Expo will play a role in policy guidance, standard setting, and ecosystem collaboration within the healthcare big data sector [2] - Future collaboration with Guizhou will focus on integrating industry data spaces with urban data spaces and implementing a personal health account system [2]